Ibrutinib Impurity N9 CAS 86953-81-3
| CAS No. | 86953-81-3 |
| Molecular Formula | C10H19NO3 |
| Molecular Weight | 201.26 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.
CATO supplies Ibrutinib Impurity N9 (CAS 86953-81-3), a pharmacopoeial impurity reference standard (molecular formula C10H19NO3, MW 201.26 g/mol) used for the identification and quantification of trace impurities in APIs.
Based on its molecular formula C10H19NO3, Ibrutinib Impurity N9 contains an amino-acid-derived structure, an amide group, a hydroxyl group, an ether linkage; these features give the compound characteristic functional-group stretching vibrations in infrared spectroscopy. The molecular weight of 201.26 g/mol is directly relevant to the identification of the molecular ion in mass spectrometry. Nitrogen-containing functional groups confer excellent ionization efficiency in positive-ion electrospray (ESI) mode, making the compound well suited to LC-MS/MS analysis.
CATO manufactures Ibrutinib Impurity N9 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C10H19NO3 |
| Molecular Weight | 201.26 g/mol |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in methanol, ethanol, DMSO |
| Stability | Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening |
| Degree of Unsaturation (DBE) | 2.0 |
| CAS Registry Year (est.) | 1981 |
| Nitrogen Atoms | 1 |
Related Ibrutinib Standards
- Ibrutinib Impurity 6 (CAS 143900-44-1)
- Ibrutinib Impurity 80 (CAS 109384-19-2)
- Ibrutinib Impurity N34 (CAS 98977-36-7)
- Ibrutinib Impurity 98 (CAS CATO-C4X-106498)
- Ibrutinib Impurity N2 (CAS 43191-23-7)
- Ibrutinib Impurity 54 (CAS 1260862-85-8)
- Ibrutinib Impurity 193 (CAS 60034-89-1)
- Ibrutinib Impurity 79 (CAS 21218-94-0)
Recommended Standards
- Caprylylglycine (CAS 14246-53-8)
- Boc-D-Pro-ol (CAS 83435-58-9)
- Ramelteon Impurity 6（Cis-trans isomerism mixture） (CAS CATO-C4X-26226)
- 3-(3-Methylphenethyl)-1h-pyrazol-5-amine (CAS 1000895-63-5)
- Ursodeoxycholic Acid Impurity 115 (CAS 2446100-56-5)
- Sitafloxacin Impurity 36 (CAS CATO-C4X-115536)
- Imatinib EP Impurity A (CAS 55314-16-4)
- 4-Propylbicyclo[2.2.2]Octan-1-ol (CAS 76921-54-5)
- [(3Z)-5-Chloro-1-[(3,4-dichlorophenyl)methyl]-2-oxo-2,3-dihydro-1H-indol-3-ylidene]amino pentanoate (CAS 320420-74-4)
- 1-(3-Chlorophenyl)-2,6-dimethyl-4,5,6,7-tetrahydro-1H-indol-4-one (CAS 1022879-87-3)
- 5-(4-Chlorophenyl)-2-{[(3-chlorophenyl)methyl]sulfanyl}pyrimidine (CAS 344281-86-3)
- 2-(Chloromethyl)-3-(difluoromethyl)-4-hydroxypyridine (CAS 1806774-71-9)
- 2-(1-Phenyl-1h-pyrazol-4-yl)cyclopropan-1-amine (CAS 1157139-81-5)
- Fragment-[7-31]-Liraglutide (CAS CATO-C4X-199239)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com